Unknown

Dataset Information

0

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.


ABSTRACT: Glucagon-like peptide-1 (GLP-1) released from the gut functions as an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that controls feeding and drinking behavior and gastric emptying and elicits neuroendocrine responses including development of conditioned taste aversion. Although GLP-1 receptor (GLP-1R) agonists are under development for the treatment of diabetes, GLP-1 administration may increase blood pressure and heart rate in vivo. We report here that centrally and peripherally administered GLP-1R agonists dose-dependently increased blood pressure and heart rate. GLP-1R activation induced c-fos expression in the adrenal medulla and neurons in autonomic control sites in the rat brain, including medullary catecholamine neurons providing input to sympathetic preganglionic neurons. Furthermore, GLP-1R agonists rapidly activated tyrosine hydroxylase transcription in brainstem catecholamine neurons. These findings suggest that the central GLP-1 system represents a regulator of sympathetic outflow leading to downstream activation of cardiovascular responses in vivo.

SUBMITTER: Yamamoto H 

PROVIDER: S-EPMC151031 | biostudies-literature | 2002 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

Yamamoto Hiroshi H   Lee Charlotte E CE   Marcus Jacob N JN   Williams Todd D TD   Overton J Michael JM   Lopez Marisol E ME   Hollenberg Anthony N AN   Baggio Laurie L   Saper Clifford B CB   Drucker Daniel J DJ   Elmquist Joel K JK  

The Journal of clinical investigation 20020701 1


Glucagon-like peptide-1 (GLP-1) released from the gut functions as an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that controls feeding and drinking behavior and gastric emptying and elicits neuroendocrine responses including development of conditioned taste aversion. Although GLP-1 receptor (GLP-1R) agonists are under development for the treatment of diabetes, GLP-1 administration may increase blood pressure and heart rate in vivo. We report here that centrall  ...[more]

Similar Datasets

| S-EPMC5237337 | biostudies-literature
| S-EPMC4519109 | biostudies-literature
| S-EPMC4824796 | biostudies-literature
| S-EPMC6408997 | biostudies-literature
| S-EPMC6351851 | biostudies-literature
2022-12-09 | GSE211105 | GEO